Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
フルベストラント製剤
Document Type and Number:
Japanese Patent JP3713237
Kind Code:
B2
Abstract:
The invention relates to a novel sustained release pharmaceutical formulation adapted for administration by injection containing the compound 7±-[9-(4,4,5,5,5-pentafluoropentylsulphinyl)nonyl]oestra-1,3,5(10)-triene-3,17²-diol, more particularly to a formulation adapted for administration by injection containing the compound 7±-[9-(4,4,5,5,5-pentafluoropentylsulphinyl)nonyl]oestra-1,3,5(10)-triene-3,17²-diol in solution in a ricinoleate vehicle which additionally comprises at least one alcohol and a non-aqueous ester solvent which is miscible in the ricinoleate vehicle.

Inventors:
Evans, John Raymond
Grundy, Rosalind Ursula
Application Number:
JP2001551480A
Publication Date:
November 09, 2005
Filing Date:
January 08, 2001
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
AstraZeneca Activrag
International Classes:
A61K9/00; A61K31/565; A61K31/5685; A61K36/47; A61K47/00; A61K47/10; A61K9/08; A61K47/12; A61K47/14; A61P5/32; A61P15/00; A61P35/00; C07J31/00; A61K; A61P; (IPC1-7): A61K31/565; A61K47/10; A61K47/12; A61K47/44; A61P15/00; A61P35/00
Domestic Patent References:
JP11501649A
JP43027327B1
JP9208496A
JP10152438A
JP10203982A
JP11158200A
Foreign References:
US5183814
Attorney, Agent or Firm:
Kazuo Shamoto
Tadashi Masui
Yasushi Kobayashi
Akio Chiba
Hiroyuki Tomita